SCHEMBL23830674

SCHEMBL23830674

O=C(O)N1CC(Oc2cc3[nH]c(=O)ccc3cc2F)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.39
RBP4 P02753 1/20 0.35
MGLL Q99685 5/20 0.34
RXFP1 Q9HBX9 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
RIPK1 Q13546 1/20 0.33
CA12 O43570 2/20 0.33
CA9 Q16790 2/20 0.33
MAPK1 P28482 1/20 0.33
F11 P03951 1/20 0.33
CA1 P00915 1/20 0.33
CA3 P07451 1/20 0.33
CA4 P22748 1/20 0.33
CA6 P23280 1/20 0.33
CA5A P35218 1/20 0.33
CA7 P43166 1/20 0.33
CA13 Q8N1Q1 1/20 0.33
CA14 Q9ULX7 1/20 0.33
CA5B Q9Y2D0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23830879 0.84 KDM4E (0.45) HRH3
SCHEMBL23830542 0.79 SLC6A2 (0.44) CA12CA9MAPK1F11CA1
SCHEMBL20165828 0.77 RBP4 (0.40) RBP4RIPK1
SCHEMBL23842744 0.77 RIPK1 (0.67) HRH3MGLLRIPK1
SCHEMBL28922028 0.74 NCEH1 (0.41) MGLLRXFP1MEN1KMT2AMAPK1
SCHEMBL1081628 0.71 CA12 (0.46) CA12CA9MAPK1F11CA1
SCHEMBL4213774 0.71 RBP4 (0.41) HRH3RBP4RIPK1
SCHEMBL20165896 0.69 RBP4 (0.41) RBP4RIPK1
SCHEMBL25210527 0.68 CA12 (0.42) CA12CA9MAPK1F11CA1
SCHEMBL1081106 0.68 CA12 (0.52) RXFP1CA12CA9MAPK1F11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210292305-A1 Cyclic Ureas SIRONAX LTD (KY) 2021-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210292305-A1 Cyclic Ureas RIPK1, RIPK3, RIPK4 HRH3 1156/4885RBP4 2138/4885MGLL 4549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.